Kanyr Pharma
PrivateLast Round
Grant
Jun 5, 2023
Total Funding Raised
$680,000
Company Overview
Kanyr Pharma operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Grant round in June 2023.
Kanyr Pharma is a biotechnology company that develops innovative protein tyrosine phosphatase (PTP) inhibitor-based therapies for the treatment of cancer and other human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kanyr Pharma Comparables
Compare Kanyr Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DepYmed, Inc. | 84% | |
| BridgeBio Pharma, Inc. | 76% | |
| Jacobio Pharmaceuticals Group Co Ltd | 72% |
For institutional investors. Book with your work email.
Kanyr Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 5, 2023 | ||||
| Grant | Jun 17, 2020 |
For institutional investors. Book with your work email.
Kanyr Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Grant |
| Mitacs | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| MEDTEQ+ | Grant |
Kanyr Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kanyr Pharma's valuation, stock price, and market status.
Is Kanyr Pharma a public or private company?
Kanyr Pharma is a private company.
What is the current stock price of Kanyr Pharma?
Kanyr Pharma is a private company, so its shares have no public market price. Caplight tracks Kanyr Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kanyr Pharma worth (valuation)?
Valuation information for Kanyr Pharma is not publicly available.
Can I buy Kanyr Pharma stock?
Kanyr Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kanyr Pharma's last funding round?
Kanyr Pharma's most recent funding round was Grant on June 5, 2023.
Who are the main investors in Kanyr Pharma?
Key investors in Kanyr Pharma include Consortium Québécois sur la découverte du médicament.
Will Kanyr Pharma IPO soon?
No public IPO plans have been announced for Kanyr Pharma.
How can I track Kanyr Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Kanyr Pharma's shares on secondary markets.